Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDCD4 | Q53EL6 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | GRM2 | Q14416 | 10/20 | 0.42 |
| ▸ | PPARG | P37231 | 2/20 | 0.42 |
| ▸ | SIRT2 | Q8IXJ6 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16423849 | 1.00 | PDCD4 (0.56) | PDCD4CYP1A2GRM2PPARGSIRT2 | |
| SCHEMBL8164022 | 1.00 | PDCD4 (0.56) | PDCD4CYP1A2GRM2PPARGSIRT2 | |
| SCHEMBL16341541 | 0.98 | PDCD4 (0.58) | PDCD4CYP1A2GRM2PPARGSIRT2 | |
| SCHEMBL16341658 | 0.98 | PDCD4 (0.58) | PDCD4CYP1A2GRM2PPARGSIRT2 | |
| SCHEMBL16341360 | 0.98 | PDCD4 (0.58) | PDCD4CYP1A2GRM2PPARGSIRT2 | |
| SCHEMBL16341423 | 0.98 | PDCD4 (0.58) | PDCD4CYP1A2GRM2PPARGSIRT2 | |
| SCHEMBL17027596 | 0.98 | PDCD4 (0.58) | PDCD4CYP1A2GRM2PPARGSIRT2 | |
| SCHEMBL3662367 | 0.98 | PDCD4 (0.58) | PDCD4CYP1A2GRM2PPARGSIRT2 | |
| SCHEMBL16340997 | 0.98 | PDCD4 (0.58) | PDCD4CYP1A2GRM2PPARGSIRT2 | |
| SCHEMBL16340799 | 0.98 | PDCD4 (0.58) | PDCD4CYP1A2GRM2PPARGSIRT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 806 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122070915-A | Use of Maxolides for the preparation of a medicament for the treatment of pulmonary fibrosis | 上海济昀生物科技有限公司 | 2026-05-22 | — | — | CN | claimed |
| US-20260123657-A1 | COMPOSITIONS AND METHODS FOR MASKING OFF-NOTES IN CONSUMABLES | GIVAUDAN SA (CH) | 2026-05-07 | — | — | US | claimed |
| US-20260096574-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | VOYAGE FOODS INC (US) | 2026-04-09 | — | — | US | claimed |
| US-12575585-B2 | Crumb chocolate flavor compositions | MARS, INCORPORATED (US) | 2026-03-17 | — | — | US | claimed |
| US-20260007144-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | VOYAGE FOODS INC (US) | 2026-01-08 | — | — | US | claimed |
| US-20260002184-A1 | METHOD FOR PRODUCING MASSOIA LACTONE FROM LIAMOCINS | US AGRICULTURE (US) | 2026-01-01 | — | — | US | claimed |
| US-20250352444-A1 | Antimicrobial mixtures | SYMRISE AG (DE) | 2025-11-20 | — | — | US | claimed |
| US-20250324983-A1 | METHOD AND APPARATUS FOR CONTROLLING ARTHROPODS USING MASSOIA ESSENTIAL OIL AND RELATED PYRONES | US AGRICULTURE (US) | 2025-10-23 | — | — | US | claimed |
| US-20250325463-A1 | COMPOSITIONS (III) | SYMRISE AG (DE) | 2025-10-23 | — | — | US | claimed |
| EP-3911795-B1 | METHOD OF STRENGTHENING NON-KERATINOUS FIBERS, AND USES THEREOF | ISP INVESTMENTS LLC (US) | 2025-10-01 | — | — | EP | claimed |
| US-20030055105-A1 | Anticancer agents, perfumes or foods and drinks containing omega-hydroxyfatty acids | SODA AROMATIC CO., LTD. A JAPANESE CORPORATION (JP) | 2003-03-20 | — | — | US | claimed |
| EP-1249236-A1 | ANTICANCER AGENTS, PERFUMES OR FOODS AND DRINKS CONTAINING $g(v)-HYDROXYFATTY ACIDS | SODA AROMATIC COMPANY, LIMITED (JP) | 2002-10-16 | — | — | EP | claimed |
| US-6187741-B1 | HIGH YIELDS OF DELTA-DECALACTONE AND DELTA-DODECALACTONE FROM THE CORRESPONDING UNSATURATED STARTING MATERIALS IS CARRIED OUT UNDER OXIDATIVE GROWTH CONDITIONS USING A SACCHAROMYCES SPECIES. | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2001-02-13 | — | — | US | claimed |
| US-6117835-A | MIXNG AQUEOUS NUTRIENT MEDIUM PHASE AND ORGANIC PHASE COMPRISING FATTY ACID TRIGLYCERIDE OR HYDROCARBON TOGETHER WITH AGITATION TO FORM A REACTION MEDIUM; FEEDING DEXTROSE; SUPPLYING OXYGEN TO FERMENT IN PRESENCE OF YEAST | INTERNATIONAL FLAVORS & FRAGRANCES INC (US) | 2000-09-12 | — | — | US | claimed |
| US-6025170-A | HYDROGENATION OF 2-DECEN-5-OLIDE OR 2-DODECEN-5-OLIDE, OR A DERIVATIVE THEREOF, BY A CLOSTRIDIUM GENUS BACTERIA | FIRMENICH SA (CH) | 2000-02-15 | — | — | US | claimed |
| EP-0952226-A1 | Process for preparing saturated lactones, products produced therefrom and organoleptic uses of said products | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1999-10-27 | — | — | EP | claimed |
| EP-0899342-A2 | Process for the biotechnological production of Delta-decalactone and Delta-dodecalactone | FIRMENICH SA (CH) | 1999-03-03 | — | — | EP | claimed |
| EP-0425001-B1 | Natural delta-lactones and process of the production thereof | TASTEMAKER BV (NL) | 1996-01-17 | — | — | EP | claimed |
| US-5128261-A | NATURAL DELTA-LACTONES AND PROCESS OF THE PRODUCTION THEREOF | PFW (NEDERLAND) B.V. (NL) | 1992-07-07 | — | — | US | claimed |
| EP-0425001-A1 | Natural delta-lactones and process of the production thereof | Tastemaker B.V. (NL) | 1991-05-02 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260007144-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | HAAO, PTGES2, PTGES | PDCD4 3060/4885CYP1A2 274/4885GRM2 690/4885 |
| US-20250324983-A1 | METHOD AND APPARATUS FOR CONTROLLING ARTHROPODS USING MASSOIA ESSENTIAL OIL AND RELATED PYRONES | AMY1A, MSMO1, CHIA | PDCD4 514/4885CYP1A2 106/4885GRM2 2091/4885 |
| US-20030055105-A1 | Anticancer agents, perfumes or foods and drinks containing omega-hydroxyfatty acids | ALOX5, ELOVL5, ELOVL3 | PDCD4 1717/4885CYP1A2 640/4885GRM2 4516/4885 |
| US-20250352444-A1 | Antimicrobial mixtures | LRBA, MGLL, TAS2R50 | PDCD4 1156/4885CYP1A2 3031/4885GRM2 3442/4885 |
| US-20260002184-A1 | METHOD FOR PRODUCING MASSOIA LACTONE FROM LIAMOCINS | COASY, MLYCD, LDHA | PDCD4 1657/4885CYP1A2 2209/4885GRM2 2721/4885 |
| US-20260123657-A1 | COMPOSITIONS AND METHODS FOR MASKING OFF-NOTES IN CONSUMABLES | RBP4, RBP1, PROC | PDCD4 2529/4885CYP1A2 4770/4885GRM2 1879/4885 |
| US-20260096574-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | HAAO, HTR6, SCD | PDCD4 2542/4885CYP1A2 1105/4885GRM2 1986/4885 |
| US-12575585-B2 | Crumb chocolate flavor compositions | DAGLA, MSMO1, HSD3B2 | PDCD4 914/4885CYP1A2 1633/4885GRM2 1216/4885 |
| US-20250325463-A1 | COMPOSITIONS (III) | NISCH, TAS1R3, TAS2R3 | PDCD4 2984/4885CYP1A2 1689/4885GRM2 2896/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.